Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Journal:

Journal of the American Society of Nephrology

Published:

2026-03-31

DOI:

10.1681/asn.0000001071

Affiliations:

20

Authors:

17

Go to article

Institutions	Authors	Share
Bayer U.S., United States of America (USA)	2.000000	0.12
Bayer, Germany	1.000000	0.06
Duke University Health System, United States of America (USA)	1.000000	0.06
National Institute of Medical Science and Nutrition Salvador Zubiran (INCMNSZ), Mexico	1.000000	0.06
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	1.000000	0.06
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.06
University of Maryland, Baltimore (UMB), United States of America (USA)	1.000000	0.06
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.06
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.06
The University of Tokyo (UTokyo), Japan	1.000000	0.06
Kurume University, Japan	1.000000	0.06
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.06
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.06
Richard L. Roudebush VA Medical Center, United States of America (USA)	0.500000	0.03
Indiana University (IU), United States of America (USA)	0.500000	0.03
KfH-Zentrum in München-Schwabing, Germany	0.500000	0.03
Steno Diabetes Center Copenhagen (SDCC), Denmark	0.500000	0.03
University of Erlangen-Nuremberg (FAU), Germany	0.500000	0.03
University of Copenhagen (UCPH), Denmark	0.500000	0.03

Interested in Cardiovascular Medicine and Haematology?